Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer

Background/AimsThe benefit of second-line chemotherapy (SL) after failed first-line chemotherapy (FL) in patients with advanced pancreatic cancer has not yet been established. We evaluated the clinical characteristics affecting the benefits of SL compared to best supportive care (BSC), identified th...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Jeung Eun Lee, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Si Young Song, Seungmin Bang
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Gastroenterology Council for Gut and Liver 2020-01-01
Σειρά:	Gut and Liver
Θέματα:	pancreatic neoplasms second line chemotherapy prognostic model
Διαθέσιμο Online:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl18419
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!